Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Erythroferrone Regulates Bone Remodeling in β-Thalassemia

Melanie Castro-Mollo, MD, Marc Ruiz Martinez, PhD, Maria Feola, PhD, Anisa Azatovna Gumerova, MD, Carla Casu, PhD, Robert E Fleming, MD, Stefano Rivella, PhD, Tony Yuen, PhD, Mone Zaidi, MD PhD, Yelena Ginzburg, MD

Blood (2019) 134 (Supplement_1): 2.

https://doi.org/10.1182/blood-2019-125822

Published: 2019

Journal Articles

Role of Sclerostin in Multiple Myeloma Progression

Cristina Panaroni, PhD, Keertik Fulzele, PhD, Ka Tat Siu, PhD, Peter Wang, BS, Noopur Raje, MD

Blood (2017) 130 (Supplement 1): 4341.

https://doi.org/10.1182/blood.V130.Suppl_1.4341.4341

Published: 2017

Journal Articles

Bone-Targeted Pharmacological Inhibition of Notch Signaling As a Novel Approach to Inhibit Myeloma Growth and Bone Destruction

Jesus Delgado-Calle, PhD, Gerald Wu, Jessica Nelson, Emily G Atkinson, Kevin McAndrews, Lifeng Xiao, Frank H Ebetino, Robert K Boeckman, Jr., David David Roodman, MD PhD, Teresita Bellido

Blood (2017) 130 (Supplement 1): 4419.

https://doi.org/10.1182/blood.V130.Suppl_1.4419.4419

Published: 2017

Journal Articles

Genetic Sost Deletion and Pharmacological Inhibition of Sclerostin Prevent Multiple Myeloma-Induced Bone Loss without Affecting Tumor Growth

Jesus Delgado-Calle, PhD, Judith Anderson, Meloney D. Cregor, Dan Zhou, Lilian I. Plotkin, PhD, Teresita M. Bellido, PhD, G. David Roodman, MD PhD

Blood (2016) 128 (22): 1136.

https://doi.org/10.1182/blood.V128.22.1136.1136

Published: 2016

Journal Articles

Effect of the Wnt-Signaling Inhibitor Sclerostin and Bone Marrow Adipocytes on Multiple Myeloma

Cristina Panaroni, PhD, Ka Tat Siu, PhD, Keertik S Fulzele, PhD, Janani Ramachandran, MA, Noopur Raje, MD

Blood (2016) 128 (22): 2077.

https://doi.org/10.1182/blood.V128.22.2077.2077

Published: 2016

Journal Articles

Notch- and TNFα-Activated Signaling Pathways Mediate Osteocyte Apoptosis Triggered By Multiple Myeloma Cells

Jesus Delgado-Calle, PhD, Judith Anderson, Lilian I. Plotkin, PhD, Teresita Bellido, PhD, G. David Roodman, MD PhD

Blood (2014) 124 (21): 3354.

https://doi.org/10.1182/blood.V124.21.3354.3354

Published: 2014

Journal Articles

Direct Cell-To-Cell Interactions Between Osteocytes and Multiple Myeloma (MM) Cells Upregulate Sost and Downregulate OPG Expression In Osteocytes: Evidence For Osteocytic Contributions To MM-Induced Bone Disease

Jesus Delgado Calle, PhD, Teresita Bellido, PhD, G. David David Roodman, MD, PhD

Blood (2013) 122 (21): 3140.

https://doi.org/10.1182/blood.V122.21.3140.3140

Published: 2013

Journal Articles

Increased Sclerostin Secretion in Multiple Myeloma Plays a Central Role in Osteolytic Bone Disease

Homare Eda, Loredana Santo, Diana Cirstea, Andrew J. Yee, Anuj Mahindra, Tyler Scullen, Neeharika Nemani, Yuko Mishima, Sonia Vallet, Noopur Raje

Blood (2012) 120 (21): 3989.

https://doi.org/10.1182/blood.V120.21.3989.3989

Published: 2012

Journal Articles

Osteocytes Embedded Inside Bone Are Essential for G-CSF-Induced Hematopoietic Stem/Progenitor Mobilization

Noboru Asada, MD, Yoshio Katayama, MD, PhD, Mari Sato, DDS, PhD, Kentaro Minagawa, MD, PhD, Kanako Wakahashi, MD, Hiroki Kawano, MD, Yuko Kawano, MD, Akiko Sada, MD, PhD, Kyoji Ikeda, MD, Toshimitsu Matsui, MD, PhD, Mitsune Tanimoto

Blood (2011) 118 (21): 721.

https://doi.org/10.1182/blood.V118.21.721.721

Published: 2011

Journal Articles

Absence of the Wnt Antagonist Sclerostin Adversely Affects B Cell Development in the Bone Marrow Niche

Corey J Cain, Randell Rueda, Bryce T McLelland, Nicole Collette, Ph.D, Gabriela Loots, Ph.D, Jennifer O Manilay, Ph.D

Blood (2011) 118 (21): 220.

https://doi.org/10.1182/blood.V118.21.220.220

Published: 2011

Journal Articles

Increased Sclerostin Secretion in Multiple Myeloma Results in Stimulation of Osteoclastogenesis and Inhibition of Osteoblastogenesis

Homare Eda, MD, PhD, Loredana Santo, MD, Diana D. Cirstea, MD, Samantha Pozzi, MD, Miriam Canavese, PhD, Tyler A. Scullen, BA, Sonia Vallet, MD, Noopur S. Raje, MD

Blood (2011) 118 (21): 1819.

https://doi.org/10.1182/blood.V118.21.1819.1819

Published: 2011

NARROW

Erythroferrone Regulates Bone Remodeling in β-Thalassemia

Role of Sclerostin in Multiple Myeloma Progression

Bone-Targeted Pharmacological Inhibition of Notch Signaling As a Novel Approach to Inhibit Myeloma Growth and Bone Destruction

Genetic Sost Deletion and Pharmacological Inhibition of Sclerostin Prevent Multiple Myeloma-Induced Bone Loss without Affecting Tumor Growth

Effect of the Wnt-Signaling Inhibitor Sclerostin and Bone Marrow Adipocytes on Multiple Myeloma

Notch- and TNFα-Activated Signaling Pathways Mediate Osteocyte Apoptosis Triggered By Multiple Myeloma Cells

Direct Cell-To-Cell Interactions Between Osteocytes and Multiple Myeloma (MM) Cells Upregulate Sost and Downregulate OPG Expression In Osteocytes: Evidence For Osteocytic Contributions To MM-Induced Bone Disease

Increased Sclerostin Secretion in Multiple Myeloma Plays a Central Role in Osteolytic Bone Disease

Osteocytes Embedded Inside Bone Are Essential for G-CSF-Induced Hematopoietic Stem/Progenitor Mobilization

Absence of the Wnt Antagonist Sclerostin Adversely Affects B Cell Development in the Bone Marrow Niche

Increased Sclerostin Secretion in Multiple Myeloma Results in Stimulation of Osteoclastogenesis and Inhibition of Osteoblastogenesis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only